Logo des Robert Koch-InstitutLogo des Robert Koch-Institut
Publikationsserver des Robert Koch-Institutsedoc
de|en
Publikation anzeigen 
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
JavaScript is disabled for your browser. Some features of this site may not work without it.
Gesamter edoc-ServerBereiche & SammlungenTitelAutorSchlagwortDiese SammlungTitelAutorSchlagwort
PublizierenEinloggenRegistrierenHilfe
StatistikNutzungsstatistik
Gesamter edoc-ServerBereiche & SammlungenTitelAutorSchlagwortDiese SammlungTitelAutorSchlagwort
PublizierenEinloggenRegistrierenHilfe
StatistikNutzungsstatistik
Publikation anzeigen 
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
2022-12-08Zeitschriftenartikel
Different phenotypes of drug-induced anaphylaxis—Data from the European Anaphylaxis Registry
Hanschmann, Theresa
Francuzik, Wojciech
Dölle-Bierke, Sabine
Scherer Hofmeier, Kathrin
Grabenhenrich, Linus
Ruëff, Franziska
Renaudin, Jean-Marie
Pföhler, Claudia
Treudler, Regina
Bilò, M. Beatrice
Lang, Roland
Ensina, Luis Felipe
Christoff, George
Cardona, Victoria
Wagner, Nicola
Reider, Norbert
Müller, Sabine
Dickel, Heinrich
Worm, Margitta
Background Drugs are a frequent cause of severe anaphylactic reactions. Here, we analyze a large dataset on drug induced anaphylaxis regarding elicitors, risk factors, symptoms, and treatment. Methods Data from the European Anaphylaxis Registry (2007–2019) with 1815 reported cases of drug-induced anaphylaxis were studied accordingly. Results Drugs are the third most frequent cause of anaphylaxis reported in the Anaphylaxis Registry. Among the eliciting groups of drugs analgesics and antibiotics were far most often reported. Female and senior patients were more frequently affected, while the number of children with DIA was low. DIA patients had symptoms affecting the skin and mucous membranes (n = 1525, 84.02%), the respiratory (n = 1300, 71.63%), the cardiovascular (n = 1251, 68.93%) and the gastrointestinal system (n = 549, 30.25%). Drugs caused significant more severe reactions, occurred more often in medical facilities and led to increased hospitalization rates in comparison to food and insect venom induced anaphylaxis. Adrenaline was used more often in patients with DIA than in anaphylaxis due to other causes. Patients with skin symptoms received more antihistamines and corticosteroids in the acute treatment, while gastrointestinal symptoms led to less adrenaline use. Conclusion The study contributes to a better understanding of DIA, with a large number of cases from Europe supporting previous data, e.g., analgesics and antibiotics being the most frequent culprits for DIA. Female gender and higher age are relevant risk factors and despite clear recommendations, the emergency treatment of DIA is not administered according to the guidelines.
Dateien zu dieser Publikation
Thumbnail
Allergy - 2022 - Hanschmann - Different phenotypes of drug‐induced anaphylaxis Data from the European Anaphylaxis Registry.pdf — PDF — 2.784 Mb
MD5: 7b9aeace69e2b087e5e590b286585e70
Zitieren
BibTeX
EndNote
RIS
(CC BY-NC 3.0 DE) Namensnennung - Nicht kommerziell 3.0 Deutschland(CC BY-NC 3.0 DE) Namensnennung - Nicht kommerziell 3.0 Deutschland(CC BY-NC 3.0 DE) Namensnennung - Nicht kommerziell 3.0 Deutschland
Zur Langanzeige
Nutzungsbedingungen Impressum Leitlinien Datenschutzerklärung Kontakt

Das Robert Koch-Institut ist ein Bundesinstitut im

Geschäftsbereich des Bundesministeriums für Gesundheit

© Robert Koch Institut

Alle Rechte vorbehalten, soweit nicht ausdrücklich anders vermerkt.